Page last updated: 2024-09-05

sorafenib and imiquimod

sorafenib has been researched along with imiquimod in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(imiquimod)
Trials
(imiquimod)
Recent Studies (post-2010) (imiquimod)
6,5207305,2513,2642841,963

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)imiquimod (IC50)
Histamine H2 receptorHomo sapiens (human)1.506
Alpha-1D adrenergic receptorHomo sapiens (human)2.621
Adenosine receptor A2aHomo sapiens (human)5.32
7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)0.646

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inoue, K; Kamada, M; Karashima, T; Kawada, C; Komatsu, T; Kuroda, N; Niimura, M; Shuin, T; Udaka, K1

Other Studies

1 other study(ies) available for sorafenib and imiquimod

ArticleYear
Novel combination therapy with imiquimod and sorafenib for renal cell carcinoma.
    International journal of urology : official journal of the Japanese Urological Association, 2014, Volume: 21, Issue:7

    Topics: Adenocarcinoma; Aminoquinolines; Animals; Antineoplastic Agents; Carcinoma, Renal Cell; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Drug Therapy, Combination; Female; Imiquimod; Kidney Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Treatment Outcome; Vascular Endothelial Growth Factor A

2014